 growth factor suppresses acute chronic arthritis experimental animals Systemic administration cytokine TGF development polyarthritis susceptible rats TGF administration micrograms/animal initiated day arthritogenic dose streptococcal cell wall SCW fragments joint swelling distortion acute phase articular index AI chronic phase AI disease TGF evolution arthritis administration acute phase disease Histopathological examination joint systemic TGF beta treatment inflammatory cell infiltration pannus formation joint erosion Consistent inhibition inflammatory cell recruitment synovium TGF leukocytosis chronic phase arthritis Control animals TGF beta regimen discernable immunosuppressive toxic effects wk treatment observations insight immunoregulatory effects TGF beta cytokine important therapeutic agent